Ingevity (NGVT) Expected to Announce Quarterly Earnings on Wednesday

Ingevity (NYSE:NGVT - Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 7th. Analysts expect Ingevity to post earnings of $0.74 per share and revenue of $299.13 million for the quarter. Ingevity has set its FY 2025 guidance at EPS.

Ingevity (NYSE:NGVT - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.66. The firm had revenue of $298.80 million for the quarter, compared to analysts' expectations of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. On average, analysts expect Ingevity to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Ingevity Price Performance

NGVT traded up $1.72 during midday trading on Friday, reaching $35.00. 316,144 shares of the company's stock were exchanged, compared to its average volume of 273,694. Ingevity has a 1-year low of $28.49 and a 1-year high of $56.30. The stock has a market capitalization of $1.28 billion, a PE ratio of -2.96 and a beta of 1.54. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. The business's 50-day moving average price is $38.27 and its 200 day moving average price is $41.68.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. StockNews.com downgraded Ingevity from a "buy" rating to a "hold" rating in a research report on Saturday, April 12th. BMO Capital Markets raised Ingevity from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $62.00 to $65.00 in a report on Wednesday, February 26th. Finally, Wells Fargo & Company decreased their price objective on Ingevity from $45.00 to $32.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 9th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $52.20.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.